Skip to content
StockMarketAgent
Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

OSL/OBSRV stock hub

OSL/OBSRV has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

OSL/OBSRVis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
143.6M
Oslo Børs
Market data

Price

Recent price action with selectable time range.

OSL/OBSRVOSL/OBSRV
—
Loading chart…
In the news

Latest news · OSL/OBSRV

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROE-190.4
P25 n/aP50 n/aP75 n/a
ROIC-28.3
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All OSL/OBSRV market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
173
Groups with data
11
Currency
NOK
Showing 173 of 173 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Norway
Country code
NO
Employees
4
Employees Change
-1%
Employees Change Percent
-20
Enterprise value
NOK 162.9M
Exchange
Oslo Børs
Financial currency
NOK
First seen
2026-05-10
Industry
Medical Devices
Isin
NO0010865009
Last refreshed
2026-05-10
Market cap
NOK 143.6M
Price
NOK 1.06
Price currency
NOK
Rev Per Employee
4,702,750x
Sector
Healthcare
Sic
3845
Symbol
osl/OBSRV
Website
https://observemedical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-33.86%
EV Earnings
-3.35x
EV/FCF
-6.27x
EV/Sales
8.66x
FCF yield
-18.08%
P/B ratio
4.79x
P/S ratio
7.64x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

17
MetricValue
EBIT Margin
-198.51%
EBITDA Margin
-140.19%
Gross margin
24.98%
Gross Profit
NOK 4.7M
Gross Profit Growth
121.34%
Gross Profit Growth3 Y
-19.23%
Gross Profit Growth5 Y
0.06%
Net Income
NOK -48.6M
Pretax Margin
-258.57%
Profit Margin
-258.57%
Profit Per Employee
NOK -12.2M
ROA
-19.14
Roa5y
-21.15
ROCE
-65.77
ROE
-190.4
Roe5y
-291.6
ROIC
-28.25

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

7
MetricValue
Cagr1y
-30.15%
Cagr3y
-58.5%
Cagr5y
-65.09%
Revenue Growth
1.78x
Revenue Growth Q
37.9x
Revenue Growth3 Y
-12.52x
Revenue Growth5 Y
-0.54x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

19
MetricValue
Asset Turnover
NOK 0.15
Assets
NOK 101.2M
Cash
NOK 11.5M
Current Assets
NOK 21.4M
Current Liabilities
NOK 44.4M
Debt
NOK 30.7M
Debt Equity
NOK 1.03
Debt FCF
NOK -1.18
Equity
NOK 30M
Interest Coverage
-7.22
Liabilities
NOK 71.2M
Long Term Assets
NOK 79.8M
Long Term Liabilities
NOK 26.8M
Net Cash
NOK -19.2M
Net Cash By Market Cap
NOK -13.4
Net Debt Equity
NOK 0.64
Tangible Book Value
NOK -49.8M
Tangible Book Value Per Share
NOK -0.37
WACC
6.06

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
0.48
Inventory Turnover
2.2
Net Working Capital
NOK -23.7M
Quick ratio
0.31
Working Capital
NOK -23M
Working Capital Turnover
NOK -0.53

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-336.95%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
1Y total return
-30.13%
200-day SMA
0.85
3Y total return
-92.86%
50-day SMA
1.06
50-day SMA vs 200-day SMA
50over200
5Y total return
-99.48%
All Time High
534
All Time High Change
-99.8%
All Time High Date
2021-03-09
All Time Low
0.53
All Time Low Change
100.95%
All Time Low Date
2025-10-07
ATR
0.09
Beta
0.05
Beta1y
1.78
Beta2y
1.7
Ch YTD
42.57
High
1.07
High52
2.4
High52 Date
2025-06-27
High52ch
-56.04%
Low
1.04
Low52
0.53
Low52 Date
2025-10-07
Low52ch
100.95%
Ma50ch
0%
Price vs 200-day SMA
24.48%
RSI
45.02
RSI Monthly
31.83
RSI Weekly
51.97
Sharpe ratio
0.26x
Sortino ratio
0.54
Total Return
-336.95%
Tr YTD
42.57
Tr1m
2.43%
Tr1w
-6.64%
Tr3m
62.31%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
NOK -37.3M
Operating margin
-198.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
32,272,201%
Net Borrowing
-8,720,000
Shares Insiders
11.36%
Shares Institutions
1.18%
Shares Out
136,148,412
Shares Qo Q
492.72%
Shares Yo Y
336.95%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

50
MetricValue
Adjusted FCF
NOK -26M
Average Volume
488,420.9x
Bv Per Share
0.22
CAPEX
NOK -1.1M
Ch1m
2.43
Ch1w
-6.64
Ch1y
-30.13
Ch3m
62.31
Ch3y
-95.43
Ch5y
-99.73
Ch6m
75.83
Change
-0.47%
Change From Open
-0.47
Close
1.06
Days Gap
0
Depreciation Amortization
10,970,000
Dollar Volume
219,053.9
Earnings Date
2026-04-30
EBIT
NOK -37.3M
EBITDA
NOK -26.4M
EPS
NOK -0.73
F Score
5
FCF
NOK -26M
FCF EV Yield
-15.95x
FCF Per Share
NOK -0.19
Financing CF
35,429,000
Fiscal Year End
December
Founded
2,009
Goodwill
35,159,000
Investing CF
-1,139,000
Is Primary Listing
1
Last Earnings Date
2026-04-30
Last Report Date
2025-12-31
Last Split Date
2025-01-14
Last Split Type
Reverse
Ma150
0.81
Ma150ch
30.3%
Ma20
1.11
Ma20ch
-5.21%
Net CF
9,522,000
Next Earnings Date
2026-08-25
Open
1.06
Position In Range
50
Ppne
59,000
Price Date
2026-05-08
Relative Volume
0.43x
Revenue
18,811,000x
Tr6m
75.83%
Volume
207,634
Z Score
-5.35
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does OSL/OBSRV pay a dividend?

Capital-return profile for this ticker.

Performance

OSL/OBSRV stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-30.1%
S&P 500 1Y: n/a
3Y total return
-92.9%
S&P 500 3Y: n/a
5Y total return
-99.5%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns OSL/OBSRV?

Insider, institutional, and short-interest positioning.

Institutional ownership
+1.2%
Share of float held by funds and institutions
Insider ownership
+11.4%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+337.0%
Negative means the company is buying back shares.
Technical

OSL/OBSRV momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
45.0
Neutral momentum band
Price vs 200-day MA
+24.5%
50/200-day relationship not available
Beta (5Y)
0.05
Less volatile than the market
Sharpe ratio
0.26
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About OSL/OBSRV

Hub-level FAQ points readers to the deeper analysis pages.

What is the current osl/OBSRV stock rating?

osl/OBSRV is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full osl/OBSRV analysis?

The full report lives at /stocks/osl/OBSRV/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for osl/OBSRV?

The latest report frames osl/OBSRV around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the osl/OBSRV page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.